ARTICLE | Clinical News
KD7040: Phase IIa started
December 24, 2007 8:00 AM UTC
Kalypsys began a double-blind, U.S. Phase IIa trial to compare topical KD7040 vs. placebo for 14 days in 50 PHN patients with moderate to severe pain. ...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Kalypsys began a double-blind, U.S. Phase IIa trial to compare topical KD7040 vs. placebo for 14 days in 50 PHN patients with moderate to severe pain. ...